» Articles » PMID: 22709522

Nonhuman Primate Models of Encephalitic Alphavirus Infection: Historical Review and Future Perspectives

Overview
Journal Curr Opin Virol
Publisher Elsevier
Specialty Microbiology
Date 2012 Jun 20
PMID 22709522
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Venezuelan, western, and eastern equine encephalitis viruses are New World alphaviruses that are recognized as potential agents of biowarfare and bioterrorism owing to their morbidity and mortality in humans, ease of production, considerable stability, and high infectivity in aerosols. As a result, these encephalitic alphaviruses are defined as category B select agents. Studies involving infection of nonhuman primates have been instrumental in gaining an understanding of the in vivo pathogenesis of these viruses and have provided relevant models to evaluate the efficacy of candidate human vaccines. Recent advances have led to refinement and further characterization of these models toward the goal of utility in the licensure of next-generation alphavirus vaccines and therapeutics for use in humans by the Animal Rule.

Citing Articles

Neurological manifestations of encephalitic alphaviruses, traumatic brain injuries, and organophosphorus nerve agent exposure.

VanderGiessen M, de Jager C, Leighton J, Xie H, Theus M, Johnson E Front Neurosci. 2024; 18:1514940.

PMID: 39734493 PMC: 11671522. DOI: 10.3389/fnins.2024.1514940.


Defining the Cynomolgus Macaque () Animal Model for Aerosolized Venezuelan Equine Encephalitis: Importance of Challenge Dose and Viral Subtype.

Burke C, Gardner C, Goodson A, Piper A, Erwin-Cohen R, White C Viruses. 2023; 15(12).

PMID: 38140592 PMC: 10748030. DOI: 10.3390/v15122351.


Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus.

Ma H, Albe J, Gilliland T, McMillen C, Gardner C, Boyles D PLoS Pathog. 2022; 18(6):e1009946.

PMID: 35696423 PMC: 9232170. DOI: 10.1371/journal.ppat.1009946.


Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.

Coates E, Edupuganti S, Chen G, Happe M, Strom L, Widge A Lancet Infect Dis. 2022; 22(8):1210-1220.

PMID: 35568049 PMC: 9329218. DOI: 10.1016/S1473-3099(22)00052-4.


Live Viral Vaccine Neurovirulence Screening: Current and Future Models.

May Fulton C, Bailey W Vaccines (Basel). 2021; 9(7).

PMID: 34209433 PMC: 8310194. DOI: 10.3390/vaccines9070710.